Skip to main content

Recent Patents on Anti-Cancer Drug Discovery publishes review articles on recent patents in the field of anti-cancer drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery.

Publisher: Bentham Science Publishers

Volume 1, Number 3, November 2006

Articles

c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer
pp. 305-326(22)
Authors: Robson, Sam; Pelengaris, Stella; Khan, Michael

Favourites:
ADD

Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents
pp. 327-346(20)
Authors: Ralph, Stephen J.; Low, Pauline; Dong, Langfeng; Lawen, Alfons; Neuzil, Jiri

Favourites:
ADD

Inhibition of Cyclin-Dependent Kinases - A Review of the Recent Patent Literature
pp. 357-367(11)
Authors: Basso, Andrea D.; Doll, Ronald J.

Favourites:
ADD
Favourites:
ADD

Last Generation of Amino-Bisphosphonates (N-BPs) and Cancer Angiogenesis: A New Role for These Drugs?
pp. 383-396(14)
Authors: Santini, Daniele; Schiavon, Gaia; Angeletti, Silvia; Vincenzi, Bruno; Gasparro, Simona; Grilli, Claudia; La Cesa, Annalisa; Virzi, Vladimir; Leoni, Valentina; Budillon, Alfredo; Addeo, Santolo R.; Caraglia, Michele; Dicuonzo, Giordano; Tonini, Giuseppe

Favourites:
ADD

Bortezomib in the Treatment of Cancer
pp. 397-403(7)
Authors: Roccaro, Aldo M.; Vacca, Angelo; Ribatti, Domenico

Favourites:
ADD

Patent Annotations
pp. 405-408(4)

Favourites:
ADD

Patent Selections
pp. 409-411(3)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more